524804:BOM
Aurobindo Pharma Ltd
₹1 680,80
arrow_upward
+1,17%(+19,45) 1D
15 Okt., 13:52:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524804...
Open
₹1 645,00
High
₹1 684,80
Low
₹1 645,00
Mkt. cap
976,57Â mjd
Avg. vol.
24,93Â k
Volume
155,77Â k
P/E ratio
26,26
52-wk high
₹1 739,95
52-wk low
₹1 080,10
EPS
₹64,00
Shares outstanding
585,90Â m
No. of employees
29Â k
Open
₹1 645,00
High
₹1 684,80
Low
₹1 645,00
Mkt. cap
976,57Â mjd
Avg. vol.
24,93Â k
Volume
155,77Â k
P/E ratio
26,26
52-wk high
₹1 739,95
52-wk low
₹1 080,10
EPS
₹64,00
Shares outstanding
585,90Â m
No. of employees
29Â k
News stories
From web sources and news partners
Moneycontrol.com
·
23 uur gelede
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29,2Â k
Founded1986
HeadquartersHyderabad, Andhra Pradesh, Indië
SectorPharmaceutical industry
Websiteaurobindo.com